Enzo Biochem Appoints David Bench and Kara Cannon to New Executive Management Positions
28 mars 2022 16h17 HE
|
Enzo Biochem, Inc.
NEW YORK, NY, March 28, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced two key appointments to its...
Enzo Biochem Reports Second Quarter Fiscal 2022 Result and Provides Leadership and Corporate Updates
14 mars 2022 16h10 HE
|
Enzo Biochem, Inc.
Second quarter revenue of $34.0 million increased 28% sequentially and8% year-over-year compared to FY2021 Enzo Biochem posted highest quarterly revenue in history of the Company Enzo Life Science...
Enzo Biochem to Present at the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum
10 mars 2022 08h38 HE
|
Enzo Biochem, Inc.
NEW YORK, NY, March 10, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ), a leading biosciences and diagnostics company, today announced that management will present at the KeyBanc Capital...
Enzo Biochem to Report Second Quarter 2022 Financial Results and Business Update on Monday, March 14th
08 mars 2022 08h29 HE
|
Enzo Biochem, Inc.
Conference Call and Webcast Scheduled for March 14, 2022, 4:30 pm ET NEW YORK, NY, March 08, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company,...
Hamid Erfanian and Bradley Radoff Appointed to Enzo Biochem’s Board of Directors
03 janv. 2022 16h10 HE
|
Enzo Biochem, Inc.
NEW YORK, NY, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced the appointments of Hamid...
Enzo Biochem Reports First Quarter 2022 Financial Results and Provides Business Update
15 déc. 2021 16h05 HE
|
Enzo Biochem, Inc.
1Q FY 2022 revenues of $26.5 million vs. $24.8 million in 4Q FY 2021, representing a 7% sequential increaseCompany appoints Hamid Erfanian as Chief Executive Officer Consolidated manufacturing...
Enzo Biochem to Report First Quarter 2022 Financial Results and Business Update on Wednesday, December 15th
02 déc. 2021 16h05 HE
|
Enzo Biochem, Inc.
Conference Call and Webcast Scheduled for December 15, 2021, 4:30 pm ET NEW YORK, NY, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and...
ENZO BIOCHEM REPORTS INDUCEMENT AWARDS TO NEW CHIEF EXECUTIVE OFFICER
09 nov. 2021 10h18 HE
|
Enzo Biochem, Inc.
NEW YORK, NY, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, announced today that on November 8, 2021, it...
Enzo Biochem Expands GoTestMeNow™ Online Portal to Provide Patients with Direct Access to Private Testing for Sexually Transmitted Infections
21 oct. 2021 08h38 HE
|
Enzo Biochem, Inc.
GoTestMeNow™ enables individuals to instantly and privately access physician-authorized testing for a broad range of STIs including chlamydia, gonorrhea, syphilis, HIV-1/2, hepatitis and...
HAMID ERFANAIN NAMED CHIEF EXECUTIVE OFFICER OF ENZO BIOCHEM TO ACCELERATE EXPANSION AND COMMERCIALIZATION OF KEY DIAGNOSTIC PLATFORMS
18 oct. 2021 08h17 HE
|
Enzo Biochem, Inc.
Dr. Elazar Rabbani to remain Chairperson of the Board and will assume new role as Chief Scientific Officer NEW YORK, NY, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ)...